Mechanistically, IL13Rα2 seemed to interact with JAK2 in RCC cells to activate the phosphorylation of JAK2, which may downregulate FOXO3, a representative tumor-suppressive transcriptional factor. The gene discussed is JAK2; the disease is renal cell carcinoma.